Co-treatment with letrozole during ovarian stimulation for IVF/ICSI: a systematic review and meta-analysis

NS Bülow, MD Holt, SO Skouby, KB Petersen… - Reproductive …, 2022 - Elsevier
Letrozole reduces serum oestradiol by inhibiting the aromatase enzyme and has growing
clinical indications in fertility. The available evidence of letrozole's role in ovarian stimulation …

[HTML][HTML] Stimulation for low responder patients: adjuvants during stimulation

RJ Hart - Fertility and Sterility, 2022 - Elsevier
Growth hormone, letrozole, and clomiphene citrate do not have US Food and Drug
Administration approval for their use in in vitro fertilization (IVF) cycles. However, despite this …

[HTML][HTML] The case for mild stimulation for IVF: recommendations from The International Society for Mild Approaches in Assisted Reproduction

G Nargund, AK Datta, S Campbell, P Patrizio… - Reproductive …, 2022 - Elsevier
The practice of ovarian stimulation for IVF is undergoing a fundamental re-evaluation as
recent data begin to successfully challenge the traditional paradigm that ovarian stimulation …

[HTML][HTML] Mild/moderate versus full stimulation

C Alviggi, A Conforti - Fertility and Sterility, 2022 - Elsevier
Mild stimulation (MS) consists in prescribing gonadotropin at the minimum amount alone or
in combination with other compounds. This strategy has gained popularity in assisted …

[HTML][HTML] The cumulative live birth rates of 18 593 women with progestin-primed ovarian stimulation-related protocols and frozen-thawed transfer cycles

Y Nie, W Guo, X Shen, Y Xie, Y Zeng… - Human …, 2024 - academic.oup.com
STUDY QUESTION What are the odds of achieving pregnancy when adopting progestin-
primed ovarian stimulation (PPOS)-related protocols combined with repetitive frozen-thawed …

[HTML][HTML] Cumulative live birth rate in mild versus conventional stimulation in progestin-primed ovarian stimulation protocols for individuals with low prognosis

J Zhang, M Du, C Zhang, Y Wu, Y Guan - Frontiers in Endocrinology, 2023 - frontiersin.org
Objective The purpose of this study was to evaluate the cumulative live birth rate (CLBR) of
mild stimulation and conventional stimulation for the low-prognosis population undergoing …

Comparison of the pregnancy outcomes of progestin-primed vs. antagonist ovarian stimulation in patients with poor ovarian response: a retrospective study

Z Shi, W Zhao, X Wu, X Bi - Gynecological Endocrinology, 2024 - Taylor & Francis
Objectives Progestin-primed ovarian stimulation (PPOS) is an efficient controlled ovarian
stimulation (COS) method. The study explored the pregnancy outcomes between PPOS and …

The ovarian stimulation regimen does not affect aneuploidy or blastocyst rate

M Cozzolino, L Mossetti, G Mariani, D Galliano… - Reproductive …, 2024 - Elsevier
Research question Could total dose (< 3000 IU or≥ 3000 IU) and type of exogenous
gonadotropins (ie, recombinant follicle-stimulating hormone [FSH] or human menopausal …

[HTML][HTML] Omega-3 fatty acids and L-carnitine prevent meiotic oocyte damage induced by follicular fluid from infertile women with endometriosis: an experimental study

VSI Giorgi, RA Ferriani, PA Navarro - JBRA Assisted Reproduction, 2023 - ncbi.nlm.nih.gov
Objective To assess whether follicular fluid (FF) from infertile women with endometriosis in
advanced stages [moderate/severe (EIII/IV) without or with endometrioma (Endometrioma)] …

Ultra-low–dose and very-low–dose Lupron downregulation protocols for poor responders based on POSEIDON group 3 and 4 classifications

ZW Walker, A Lanes, SS Srouji, MD Hornstein… - Journal of Assisted …, 2023 - Springer
Purpose The objective of this study was to assess if very-low–dose Lupron (VLDL) and ultra-
low–dose Lupron (ULDL) protocols can have comparable cycle outcomes when compared …